Artiva Biotherapeutics, Inc.
ARTV
$3.60
$0.020.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 6.36% | -3.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.38% | 2.88% | |||
| Operating Income | -0.38% | -2.88% | |||
| Income Before Tax | -1.29% | -4.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.29% | -4.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.29% | -4.64% | |||
| EBIT | -0.38% | -2.88% | |||
| EBITDA | -0.30% | -2.91% | |||
| EPS Basic | -0.86% | -4.48% | |||
| Normalized Basic EPS | -0.86% | -4.49% | |||
| EPS Diluted | -0.86% | -4.48% | |||
| Normalized Diluted EPS | -0.86% | -4.49% | |||
| Average Basic Shares Outstanding | 0.42% | 0.15% | |||
| Average Diluted Shares Outstanding | 0.42% | 0.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||